Preprint · CC-BY
via OpenAlex
Procyanidin C1: A Natural Dual Mode Geroprotector for Pan Organ Senescence Regulation
Jiaxin Liang, Qun Wang, Jie Li, Xueying Lu, Ling Wang, Qinghua Lyu
Preprints.org · 2026
Genomic instability
Telomere attrition
Mitochondrial dysfunction
Cellular senescence
Chronic inflammation
Senolytics
Partial reprogramming (OSK)
Review
Abstract
Cellular senescence(definition) is typically driven by DNA damage, telomere(definition) attrition, and metabolic/mitochondrial stress, resulting in a state of durable proliferative arrest accompanied by a senescence-associated secretory phenotype (SASP) that amplifies inflammation and paracrine remodeling across tissues, thereby accelerating functional decline and age-related pathologies. This review examines the molecular mechanisms and in vivo activities of procyanidin C1 (PCC1), a natural dualmode geroprotector. This dual behavior ostensibly allows PCC1 to function in an early or lowdose phase wherein PCC1 attenuates selected NFκB–driven SASP components while stabilizing redox and bioenergetic homeostasis; under high senescent burden or tumor-associated stress, elevated doses of PCC1 enable the selective reduction of refractory senescent cells and mitigation of pro-tumorigenic SASP outputs, concomitant with modulation of immune infiltration and metabolic reprogramming. PCC1 further exhibits pronounced anti-inflammatory and anti-tumor potential by reshaping inflammatory and chemotactic gradients within the tumor microenvironment. Reflecting broad multi-organ geroprotective potential, PCC1 can exert antioxidative, mitochondrial-supportive, and anti-fibrotic modulation in cardiovascular/metabolic tissues, skin, liver, kidney, and neural niches. Compared with BCL-2 inhibitors or multi-kinase senolytics(definition), PCC1 shows lower cytotoxicity toward normal proliferating cells and fewer indications of platelet or hematopoietic suppression, with its staged regulatory profile and natural scaffold suggesting a wider therapeutic window. Future priorities include quantifying dose–timing transition thresholds, establishing integrated biomarker panels, and optimizing delivery strategies to define its translational potential in precision, phase-adapted geroprotective interventions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.20944/preprints202509.1608.v3
- Canonical
- link ↗
- Fetched
- 2026-10-14 MST
Cite this
APA
Liang, J., Wang, Q., Li, J., Lu, X., Wang, L., & Lyu, Q. (2026). Procyanidin C1: A Natural Dual Mode Geroprotector for Pan Organ Senescence Regulation. <em>Preprints.org</em>. https://doi.org/10.20944/preprints202509.1608.v3
Vancouver
Liang J, Wang Q, Li J, Lu X, Wang L, Lyu Q. Procyanidin C1: A Natural Dual Mode Geroprotector for Pan Organ Senescence Regulation. Preprints.org. 2026. doi:10.20944/preprints202509.1608.v3.
BibTeX
@unpublished{jiaxin2026Procya,
title = {Procyanidin C1: A Natural Dual Mode Geroprotector for Pan Organ Senescence Regulation},
author = {Jiaxin Liang and Qun Wang and Jie Li and Xueying Lu and Ling Wang and Qinghua Lyu},
journal = {Preprints.org},
year = {2026},
doi = {10.20944/preprints202509.1608.v3},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Preprints.org 2025
Preprint · CC-BY
Procyanidin C1: A Natural Dual‑Mode Senotherapeutic for Pan‑Organ Senescence Modulation and Clearance
Preprints.org 2025
Preprint · CC-BY
Procyanidin C1: A Natural Dual-Mode Senotherapeutic for Pan-Organ Senescence Regulation
Frontiers in aging 2026
Citation only
Cellular senescence in skin inflammation: molecular mechanisms and potential clinical implications.
Frontiers in Aging 2026
Open access · CC-BY
Cellular senescence in age-related cardiovascular disease: past and future
FEBS Journal 2022
Open access · CC-BY
Therapeutic opportunities for senolysis in cardiovascular disease
Nutrients 2018
Open access · CC-BY